Stay updated on Adjuvant Pembrolizumab in N2+ NSCLC Clinical Trial

Sign up to get notified when there's something new on the Adjuvant Pembrolizumab in N2+ NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Adjuvant Pembrolizumab in N2+ NSCLC Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    Added a 'Show glossary' option and updated footer notes to include 'Last Update Submitted that Met QC Criteria', 'No FEAR Act Data', and 'Revision: v3.4.0', while removing the older labels 'Last Update Submitted that met QC Criteria', 'No FEAR Act data', and 'Revision: v3.3.4'. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2026-01-28T02:58:27.000Z thumbnail image
  2. Check
    9 days ago
    Change Detected
    Summary
    A reference to the 1994 NEJM randomized trial on preoperative chemotherapy plus surgery versus surgery alone in NSCLC was added to the page.
    Difference
    0.1%
    Check dated 2026-01-21T03:22:13.000Z thumbnail image
  3. Check
    16 days ago
    Change Detected
    Summary
    Revision tag updated to v3.3.4, replacing the previous v3.3.3; this is an internal versioning update with no effect on study content. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-01-14T02:43:35.000Z thumbnail image
  4. Check
    37 days ago
    Change Detected
    Summary
    Footer updated to show Revision: v3.3.3; HHS Vulnerability Disclosure and Revision: v3.3.2 were removed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-12-23T13:27:36.000Z thumbnail image
  5. Check
    52 days ago
    Change Detected
    Summary
    Added a background citation: Safety and activity of anti-PD-L1 antibody in patients with advanced cancer (N Engl J Med 2012;366:2455-2465) to the study page. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-12-09T00:53:28.000Z thumbnail image
  6. Check
    59 days ago
    Change Detected
    Summary
    The page shows a revision update from v3.3.1 to v3.3.2, a footer-level change that does not alter study details or user actions. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-12-01T18:51:33.000Z thumbnail image

Stay in the know with updates to Adjuvant Pembrolizumab in N2+ NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Adjuvant Pembrolizumab in N2+ NSCLC Clinical Trial page.